Such phases represent missed opportunities, as occurs when treatment is given to patients with CD4+ T cell counts ≤200 cells/mm3[20], [24], [26], [27] or signs and symptoms of AIDS-defining illnesses [22], [23], [25]. The gene discussed is CD4; the disease is AIDS.